Profound Medical (TSE:PRN) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Profound Medical Corp recently held their ‘PRO-Talk Live!’ event, attracting physicians to discuss the TULSA-PRO technology for prostate disease treatment. Key opinion leaders and experts provided insights on using TULSA-PRO, while Siemens Healthineers and Cook Medical endorsed a shared vision with Profound for a comprehensive MR solution in prostate disease management.
For further insights into TSE:PRN stock, check out TipRanks’ Stock Analysis page.